Raymond James & Associates Intercept Pharmaceuticals, Inc. Call Options Transaction History

Raymond James & Associates

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q4 2019 Feb 12, 2020	BUY	$57.36 - $124.1 $5,736 - $12,410	100 Added 0.72%	13,900 $111,000
Q3 2019 Nov 07, 2019	SELL	$58.69 - $80.46 $804,053 - $1.1 Million	-13,700 Reduced 49.82%	13,800 $1,000
Q2 2019 Aug 06, 2019	SELL	$77.77 - $120.68 $23,331 - $36,204	-300 Reduced 1.08%	27,500 $43,000
Q1 2019 May 06, 2019	BUY	$91.83 - $120.68 $2.55 Million - $3.35 Million	27,800 New	27,800 $513,000

1.04M

30K

5.9K

Ticker ICPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 41,127,400
Description
Intercept Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of therapeutics to treat progressive non-viral liver diseases in the United States, Europe, and Canada. The company markets Ocaliva, a farnesoid X receptor agonist used for the treatment of primary biliary cholangitis in combination wit...

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

Stay updated on Raymond James & Associates with notifications on news.